Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
1.783
Zitationen
13
Autoren
2007
Jahr
Abstract
A regimen of daclizumab, mycophenolate mofetil, and corticosteroids in combination with low-dose tacrolimus may be advantageous for renal function, allograft survival, and acute rejection rates, as compared with regimens containing daclizumab induction plus either low-dose cyclosporine or low-dose sirolimus or with standard-dose cyclosporine without induction. (ClinicalTrials.gov number, NCT00231764 [ClinicalTrials.gov].).
Ähnliche Arbeiten
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 · 11.295 Zit.
J Heart Lung Transplant 2021;40(4).
2021 · 6.869 Zit.
Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant
1999 · 5.278 Zit.
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 · 5.251 Zit.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
2020 · 4.904 Zit.
Autoren
Institutionen
- Lund University(SE)
- Universidade Federal de São Paulo(BR)
- Akdeniz University(TR)
- Medizinische Hochschule Hannover(DE)
- Izmir Tepecik Eğitim ve Araştırma Hastanesi(TR)
- Universitätsklinikum Erlangen(DE)
- Bellvitge University Hospital(ES)
- Charité - Universitätsmedizin Berlin(DE)
- KU Leuven(BE)
- Hôpital Notre-Dame(CA)
- Centre Hospitalier de l’Université de Montréal(CA)
- University of Alberta(CA)